TABLE 4.

P. falciparum CQ treatment failure in vivo for selected countries in Asia, 1996 to 2002

RegionCountryNo. of data points identifiedPeriodAge range (yr)Outcome classificationPeriod of follow-up (days)Median %CQ-PF (range)aMedian %CQ-TTF (range)aSource or reference
East AsiaChina11995-19966-60WHO 19732891102
Laos12001>1WHO 19732846164
Myanmar21995AllWHO 19732882 (77-86)190
Indonesia51995-1999≥5WHO 19732838 (25-82)15, 77, 78, 79, 123, 141
Malaysia119965-51WHO 19732864117
PacificPhilippines119955-67WHO 1973283814
Solomon Islands11994-19965-14WHO 1973723100
Indian subcontinentBangladesh11996-199712-60WHO 1973287766170
India1200016-72WHO 197378281
Pakistan11994AllWHO 19732846179
Middle EastAfghanistan31999>1WHO 19732869 (60-83)169
Saudi Arabia11997-19981-75WHO 1973141280
Saudi Arabia11997-19981-12WHO 197328182
  • a CQ-PF, CQ parasitologic failure (either R1-R3 or cumulative parasite failure); CQ-TF, CQ clinical failure (either ETF + LTF or cumulative clinical failure).